Benny Blunderbuss, you absolutely cannot say that about every biotech listed.
The biotechs that are worth "north of $100m" have:
- A pipeline of assets
- IP protection
- Human safety data
- Human efficacy data
- Deals
NYR-BIO3 has none of these things.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $52.72M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 23.5¢ | $24.32K | 102.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 181200 | 1 |
View Market Depth
| Last trade - 10.31am 27/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |